Tower Research Capital (TRC)’s iShares Evolved U.S. Healthcare Staples ETF IEHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-48,676
Closed -$1.87M 6920
2022
Q2
$1.87M Buy
48,676
+18,085
+59% +$732K 0.04% 399
2022
Q1
$1.34M Buy
30,591
+2,809
+10% +$119K 0.01% 689
2021
Q4
$1.26M Buy
+27,782
New +$1.21M 0.02% 576
2021
Q3
Sell
-29,579
Closed -$1.23M 6478
2021
Q2
$1.23M Sell
29,579
-17,176
-37% -$696K 0.03% 523
2021
Q1
$1.81M Buy
+46,755
New +$1.79M 0.03% 511
2020
Q4
Sell
-18,858
Closed -$635K 5526
2020
Q3
$635K Sell
18,858
-3,425
-15% -$113K 0.01% 1415
2020
Q2
$690K Buy
22,283
+6,212
+39% +$188K 0.03% 771
2020
Q1
$430K Buy
+16,071
New +$486K 0.03% 478
2019
Q4
Sell
-8,322
Closed -$238K 4673
2019
Q3
$238K Sell
8,322
-3,133
-27% -$91.5K 0.02% 920
2019
Q2
$334K Buy
+11,455
New +$319K 0.02% 640

Other funds holding IEHS

Tower Research Capital (TRC)'s IEHS Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of iShares Evolved U.S. Healthcare Staples ETF (IEHS) in Q3 2022, closing a stake of 48,676 shares — an estimated $1.87M sold.

Tower Research Capital (TRC) first reported a position in IEHS in Q2 2019 and held it in 10 quarters. The position peaked at $1.87M in Q2 2022. 2 funds tracked by Wall St. Rank hold IEHS as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining iShares Evolved U.S. Healthcare Staples ETF position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 48,676 iShares Evolved U.S. Healthcare Staples ETF shares in Q3 2022, an estimated $1.87M.
  • Tower Research Capital (TRC) first reported a position in iShares Evolved U.S. Healthcare Staples ETF in Q2 2019 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s iShares Evolved U.S. Healthcare Staples ETF position peaked at $1.87M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held iShares Evolved U.S. Healthcare Staples ETF as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.